Evidence map›Paper›PMID 24887174›Full record

ArticlePloS one2014

Generation of replication-proficient influenza virus NS1 point mutants with interferon-hyperinducer phenotype.

Maite Pérez-Cidoncha, Marian J Killip, Víctor J Asensio, Yolanda Fernández, José A Bengoechea, Richard E Randall, Juan Ortín

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Microorganisms · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Maite Pérez-CidonchaDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain; Ciber de Enfermedades Respiratorias (ISCIII), Madrid, Spain.
Marian J KillipSchool of Biology, Centre for Biomolecular Sciences, University of St Andrews, St Andrews, United Kingdom.
Víctor J AsensioFundació d'Investigació Sanitària de les Illes Balears (FISIB), Bunyola, Mallorca, Spain.
Yolanda FernándezDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain; Ciber de Enfermedades Respiratorias (ISCIII), Madrid, Spain.
José A BengoecheaLaboratory Microbial Pathogenesis, Fundació d'Investigació Sanitària de les Illes Balears (FISIB), Bunyola, Mallorca, Spain; Ciber de Enfermedades Respiratorias (ISCIII), Madrid, Spain.
Richard E RandallSchool of Biology, Centre for Biomolecular Sciences, University of St Andrews, St Andrews, United Kingdom.
Juan OrtínDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain; Ciber de Enfermedades Respiratorias (ISCIII), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESUniversity of St Andrews · GBCentro Nacional de Biotecnología · ES

Funding

Wellcome TrustWellcome Trust 087751/A/08/Z
6 · The paper itself

Abstract

The NS1 protein of influenza A viruses is the dedicated viral interferon (IFN)-antagonist. Viruses lacking NS1 protein expression cannot multiply in normal cells but are viable in cells deficient in their ability to produce or respond to IFN. Here we report an unbiased mutagenesis approach to identify positions in the influenza A NS1 protein that modulate the IFN response upon infection. A random library of virus ribonucleoproteins containing circa 40 000 point mutants in NS1 were transferred to infectious virus and amplified in MDCK cells unable to respond to interferon. Viruses that activated the interferon (IFN) response were subsequently selected by their ability to induce expression of green-fluorescent protein (GFP) following infection of A549 cells bearing an IFN promoter-dependent GFP gene. Using this approach we isolated individual mutant viruses that replicate to high titers in IFN-compromised cells but, compared to wild type viruses, induced higher levels of IFN in IFN-competent cells and had a reduced capacity to counteract exogenous IFN. Most of these viruses contained not previously reported NS1 mutations within either the RNA-binding domain, the effector domain or the linker region between them. These results indicate that subtle alterations in NS1 can reduce its effectiveness as an IFN antagonist without affecting the intrinsic capacity of the virus to multiply. The general approach reported here may facilitate the generation of replication-proficient, IFN-inducing virus mutants, that potentially could be developed as attenuated vaccines against a variety of viruses.

Indexed as

Point MutationVirus ReplicationAnimalsBase SequenceCell LineDNA PrimersDogsGreen Fluorescent ProteinsHumansImmunity, InnateInfluenza A virusInterferonsPromoter Regions, GeneticViral Nonstructural ProteinsDNA PrimersGreen Fluorescent ProteinsINS1 protein, influenza virusInterferonsViral Nonstructural Proteins

Identifiers

PMID24887174
PMCPMC4041880
OpenAlexW2026360620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.